Saturna Capital Corp Astrazeneca PLC Transaction History
Saturna Capital Corp
- $7.16 Billion
- Q1 2024
A detailed history of Saturna Capital Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Saturna Capital Corp holds 1,669,129 shares of AZN stock, worth $129 Million. This represents 1.58% of its overall portfolio holdings.
Number of Shares
1,669,129
Previous 1,273,531
31.06%
Holding current value
$129 Million
Previous $85.8 Million
31.84%
% of portfolio
1.58%
Previous 1.35%
Shares
10 transactions
Others Institutions Holding AZN
# of Institutions
1,248Shares Held
477MCall Options Held
5.99MPut Options Held
5.24M-
Price T Rowe Associates Inc Baltimore, MD61.3MShares$4.74 Billion0.51% of portfolio
-
Wellington Management Group LLP Boston, MA49.1MShares$3.8 Billion0.6% of portfolio
-
Primecap Management CO Pasadena, CA42.9MShares$3.32 Billion2.21% of portfolio
-
Capital International Investors Los Angeles, CA34.5MShares$2.67 Billion0.48% of portfolio
-
Jennison Associates LLC17.3MShares$1.34 Billion0.79% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $240B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...